Poole Sandra has filed 4 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 6500 shares of Travere Therapeutics, Inc. ($TVTX) on May 15, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Travere Therapeutics, Inc. | $TVTX | Poole Sandra | Not found | A | Common Stock | 6500 | $0.00 | 30,000.0000 | 78,888,861 | 27.66% | 0.01% |
| May 15, 2025 | Travere Therapeutics, Inc. | $TVTX | Poole Sandra | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,888,861 | 9999.99% | 0.02% |
| May 8, 2024 | Travere Therapeutics, Inc. | $TVTX | Poole Sandra | Not found | A | Common Stock | 6500 | $0.00 | 23,500.0000 | 74,267,418 | 38.24% | 0.01% |
| May 8, 2024 | Travere Therapeutics, Inc. | $TVTX | Poole Sandra | Not found | A | Stock option (right to buy) | 19500 | $0.00 | 19,500.0000 | 74,267,418 | 9999.99% | 0.03% |